Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urological conservative management of a patient with tuberous sclerosis complex (Bourneville disease).

Archivos espanoles de urologia·2009
Same author

[Laparoscopic varicocelectomy in the adult patient].

Archivos espanoles de urologia·2008
Same author

[Giant scrotal lymphedema].

Archivos espanoles de urologia·2007
Same author

[Unusual bladder stones].

Archivos espanoles de urologia·2007
Same author

[Bechet's disease. Case report].

Archivos espanoles de urologia·2007

Related Experiment Video

Updated: Jul 12, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

[Locally advanced renal cancer].

René Salas Cabrera1, Jorge Sagué Larrea, Ariel Laurencio Mena

  • 1Secci6n UrooOncológica,. Hospital Vladimir Ilich Lenin, Holguín, Cuba. revimcaribe@enet.cu

Archivos Espanoles De Urologia
|August 28, 2007
PubMed
Summary

This case report highlights a locally advanced renal carcinoma with aggressive progression despite surgery, chemotherapy, and immunotherapy. Early detection and regular follow-up are crucial for managing this challenging kidney cancer.

More Related Videos

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

Related Experiment Videos

Last Updated: Jul 12, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

Area of Science:

  • Urology
  • Oncology

Background:

  • Renal carcinoma presents a significant challenge due to its metastatic potential.
  • Prognosis is influenced by tumor size, stage, and grade.

Observation:

  • A case of a female patient with a large, locally advanced renal carcinoma is presented.
  • The patient underwent radical nephrectomy via a lumbar approach, followed by chemotherapy and immunotherapy.

Findings:

  • Despite aggressive treatment including surgery, chemotherapy, and immunotherapy, the renal carcinoma demonstrated rapid local and systemic progression.
  • This rapid evolution underscores the high aggressiveness of the tumor.

Implications:

  • Surgery remains a primary therapeutic modality for renal carcinoma, complemented by emerging immunotherapies.
  • Close, regular patient follow-up is essential for timely detection and management of recurrence.